Literature DB >> 26459764

Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation.

Olivia M Yu1, Shigeki Miyamoto2, Joan Heller Brown3.   

Abstract

The ability of a subset of G protein-coupled receptors (GPCRs) to activate RhoA endows them with unique growth-regulatory properties. Two transcriptional pathways are activated through GPCRs and RhoA, one utilizing the transcriptional coactivator myocardin-related transcription factor A (MRTF-A) and serum response factor (SRF) and the other using the transcriptional coactivator Yes-associated protein (YAP) and TEA domain family members (TEAD). These pathways have not been compared for their relative levels of importance and potential interactions in RhoA target gene expression. GPCRs for thrombin and sphingosine-1-phosphate (S1P) on human glioblastoma cells robustly couple to RhoA and induce the matricelluar protein CCN1. Knockdown of either MRTF-A or YAP abrogates S1P-stimulated CCN1 expression, demonstrating that both coactivators are required. MRTF-A and YAP are also both required for transcriptional control of other S1P-regulated genes in various cell types and for S1P-stimulated glioblastoma cell proliferation. Interactions between MRTF-A and YAP are suggested by their synergistic effects on SRE.L- and TEAD-luciferase expression. Moreover, MRTF-A and YAP associate in coimmunoprecipitations from S1P-stimulated cells. Chromatin immunoprecipitation (ChIP) analysis of the CCN1 gene promoter demonstrated that S1P increases coactivator binding at the canonical transcription factor sequences. Unexpectedly, S1P also enhances MRTF-A binding at TEA sites. Our findings reveal that GPCR- and RhoA-regulated gene expression requires dual input and integration of two distinct transcriptional pathways.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26459764      PMCID: PMC4702594          DOI: 10.1128/MCB.00772-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 2.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Role of YAP/TAZ in mechanotransduction.

Authors:  Sirio Dupont; Leonardo Morsut; Mariaceleste Aragona; Elena Enzo; Stefano Giulitti; Michelangelo Cordenonsi; Francesca Zanconato; Jimmy Le Digabel; Mattia Forcato; Silvio Bicciato; Nicola Elvassore; Stefano Piccolo
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

4.  Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin.

Authors:  Changqing Xie; Yanhong Guo; Tianqing Zhu; Jifeng Zhang; Peter X Ma; Y Eugene Chen
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

5.  Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.

Authors:  Kashelle Lockman; Jeremiah S Hinson; Matt D Medlin; Dionne Morris; Joan M Taylor; Christopher P Mack
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

6.  Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2.

Authors:  Tammy M Seasholtz; Julie Radeff-Huang; Sarah A Sagi; Rosalia Matteo; Jessica M Weems; Annemarie Stoudt Cohen; James R Feramisco; Joan Heller Brown
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

7.  Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Agnieszka Kaminska; Martin Fuchs; Gunnar Klein; Edith Podewski; Karsten Grote; Ioulia Kiian; Kai C Wollert; Andres Hilfiker; Helmut Drexler
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

Review 8.  Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.

Authors:  Bo Cen; Ahalya Selvaraj; Ron Prywes
Journal:  J Cell Biochem       Date:  2004-09-01       Impact factor: 4.429

9.  Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

Authors:  Bo Cen; Ahalya Selvaraj; Rebecca C Burgess; Johann K Hitzler; Zhigui Ma; Stephan W Morris; Ron Prywes
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

Authors:  Fa-Xing Yu; Bin Zhao; Nattapon Panupinthu; Jenna L Jewell; Ian Lian; Lloyd H Wang; Jiagang Zhao; Haixin Yuan; Karen Tumaneng; Hairi Li; Xiang-Dong Fu; Gordon B Mills; Kun-Liang Guan
Journal:  Cell       Date:  2012-08-02       Impact factor: 41.582

View more
  40 in total

1.  Nucleocytoplasmic Shuttling of the Mechanosensitive Transcription Factors MRTF and YAP /TAZ.

Authors:  Michael Kofler; András Kapus
Journal:  Methods Mol Biol       Date:  2021

2.  TGF-β1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism.

Authors:  Maria Zena Miranda; Janne Folke Bialik; Pam Speight; Qinghong Dan; Tony Yeung; Katalin Szászi; Stine F Pedersen; András Kapus
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

3.  Nucleoskeletal regulation of transcription: Actin on MRTF.

Authors:  Ekaterina Sidorenko; Maria K Vartiainen
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

4.  YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation.

Authors:  Jongshin Kim; Yoo Hyung Kim; Jaeryung Kim; Do Young Park; Hosung Bae; Da-Hye Lee; Kyun Hoo Kim; Seon Pyo Hong; Seung Pil Jang; Yoshiaki Kubota; Young-Guen Kwon; Dae-Sik Lim; Gou Young Koh
Journal:  J Clin Invest       Date:  2017-08-14       Impact factor: 14.808

5.  A forceful connection: mechanoregulation of oncogenic YAP.

Authors:  Ralph Thomas Böttcher; Zhiqi Sun; Reinhard Fässler
Journal:  EMBO J       Date:  2017-07-19       Impact factor: 11.598

Review 6.  Mechanosensing and fibrosis.

Authors:  Daniel J Tschumperlin; Giovanni Ligresti; Moira B Hilscher; Vijay H Shah
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

7.  TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression.

Authors:  Amy J Jorgenson; Kyoung Moo Choi; Delphine Sicard; Karry M J Smith; Samantha E Hiemer; Xaralabos Varelas; Daniel J Tschumperlin
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-23       Impact factor: 4.249

Review 8.  A growing role for the Hippo signaling pathway in the heart.

Authors:  Yu Zhang; Dominic P Del Re
Journal:  J Mol Med (Berl)       Date:  2017-03-10       Impact factor: 4.599

9.  Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.

Authors:  Andrew J Haak; Kathryn M Appleton; Erika M Lisabeth; Sean A Misek; Yajing Ji; Susan M Wade; Jessica L Bell; Cheryl E Rockwell; Merlin Airik; Melanie A Krook; Scott D Larsen; Monique Verhaegen; Elizabeth R Lawlor; Richard R Neubig
Journal:  Mol Cancer Ther       Date:  2016-11-11       Impact factor: 6.261

Review 10.  Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.

Authors:  Ju-Won Jang; Min-Kyu Kim; Suk-Chul Bae
Journal:  Small GTPases       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.